Advertisement
Advertisement
U.S. markets open in 8 hours 52 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Gamida Cell Ltd. (GMDA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.1600+0.2100 (+10.77%)
At close: 04:00PM EDT
2.1700 +0.01 (+0.46%)
After hours: 06:53PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.9500
Open1.9200
Bid0.0000 x 800
Ask0.0000 x 1400
Day's Range1.9200 - 2.2197
52 Week Range1.4800 - 5.9100
Volume792,297
Avg. Volume356,103
Market Cap129.567M
Beta (5Y Monthly)1.71
PE Ratio (TTM)N/A
EPS (TTM)-1.5310
Earnings DateMay 10, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for GMDA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Gamida Cell Ltd.
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
Advertisement
Advertisement